Juventus and France midfielder, Paul Pogba has been provisionally suspended from taking part in soccer attributable to an alleged anti-doping offence. The suspension was handed down by Italys nationwide anti-doping tribunal on Monday after Pogba returned a check with elevated ranges of testosterone following Juventus 3-0 victory over Udinese on August 20. France worldwide Pogba, 30, was an unused substitute however was chosen at random for post-match drug testing. If discovered responsible of doping, he might face a ban of between two and 4 years. The tribunal stated Pogba had violated anti-doping guidelines after they discovered the prohibited substance non-endogenous testosterone metabolites. Juventus stated in an announcement: “Juventus Football Club announces that today, 11 September 2023, the footballer Paul Labile Pogba received a precautionary suspension order from the National Anti-Doping Tribunal following the results of tests carried out on 20 August, 2023. “The membership reserves the appropriate to think about the following procedural steps.” Nado said Pogba had violated anti-doping rules when they found the prohibited substance “non-endogenous testosterone metabolites” and the results were “in line with the exogenous origin of the goal compounds”. Pogba has three days to produce a counter-analysis of the result to Nado. Juventus re-signed Pogba on a four-year deal in July 2022 after the player ran down his contract at Manchester United and left as a free agent. However, Pogba’s return to Turin has been beset by persistent injury problems which also saw him miss last year’s World Cup in Qatar. Pogba has played a combined total of 51 minutes as a substitute this season in games with Bologna and Empoli. Last season he managed 108 minutes over six Serie A games, three brief appearances and one assist in the Europa League, and 11 minutes in the Coppa Italia – a total of 162 minutes and no goals. The post Juventus midfielder, Paul Pogba provisionally suspended after testing positive fortestosterone appeared first on Linda Ikeji Blog.
Headline News